|
|
|
Insider
Information: |
Clements Ian |
Relationship: |
Chief Financial Officer |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
30,011 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
30,011 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
Chief Financial Officer |
2022-11-10 |
30,011 |
2019-09-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2022-11-10 |
4 |
A |
$17.05 |
$5,542 |
D/D |
325 |
30,011 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2022-05-10 |
4 |
A |
$13.57 |
$15,262 |
D/D |
1,125 |
29,686 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
28,561 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2021-11-26 |
4 |
B |
$13.90 |
$10,425 |
D/D |
750 |
18,561 |
2.74 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2021-11-24 |
4 |
B |
$14.40 |
$10,080 |
D/D |
700 |
17,811 |
2.74 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2021-11-10 |
4 |
A |
$13.52 |
$6,190 |
D/D |
458 |
17,111 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2021-10-01 |
4 |
S |
$19.26 |
$30,309 |
D/D |
(1,574) |
16,653 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2021-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
18,227 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2021-05-10 |
4 |
A |
$14.62 |
$14,342 |
D/D |
981 |
8,852 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2020-12-23 |
4/A |
B |
$18.65 |
$29,691 |
D/D |
1,592 |
7,871 |
2.74 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2020-12-23 |
4 |
B |
$18.55 |
$45,975 |
D/D |
2,470 |
7,841 |
2.74 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
Chief Financial Officer |
|
2020-11-10 |
4 |
A |
$15.27 |
$20,930 |
D/D |
1,371 |
5,371 |
0 |
- |
|
MIRM |
Mirum Pharmaceuticals, In... |
SVP Finance & Communications |
|
2019-09-06 |
4 |
B |
$11.07 |
$46,039 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|